drugset / Trial / NCT04430088

Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

NCT04430088

Phase 3 Unknown 300 enrolled Vivozon, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.

Timeline

Start
2020-06-26
Primary completion
2020-12
Completion
2021-01

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 1000 mg Intravenous

Indications